As the U.S. Food and Drug Administration’s Center for Veterinary Medicine continues to progress in implementation of its Animal and Veterinary Innovation Agenda, the center is supporting a collaborative agreement to the Reagan-Udall Foundation for the FDA (the Foundation) to conduct a strengths, weaknesses, opportunities, and threats (SWOT) analysis.

In a continuation of progress towards the implementation of the AVIA, the FDA announced support for a collaboration agreement to the Reagan-Udall Foundation for the FDA.

The event was hosted by the Reagan-Udall Foundation for the FDA. While it didn’t center on psychedelic-assisted treatments only, many exchanged views on the topic.

Read more

In Silico Methods drive scientific innovation by leveraging computer simulation instead of biological testing.

Read more